Bank Of America Corp Cytom X Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 463,854 shares of CTMX stock, worth $862,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares

463,854

Previous 2,021 22851.71%

Holding current value

$862,768

Previous $2,000 14700.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.58 - $1.14 $267,863 - $526,489	461,833 Added 22851.71%	463,854 $296,000
Q4 2024 Feb 14, 2025	SELL	$0.86 - $1.29 $15,944 - $23,916	-18,540 Reduced 90.17%	2,021 $2,000
Q3 2024 Nov 14, 2024	BUY	$1.12 - $1.51 $16,595 - $22,373	14,817 Added 257.96%	20,561 $24,000
Q2 2024 Aug 14, 2024	SELL	$1.21 - $5.13 $87,204 - $369,719	-72,070 Reduced 92.62%	5,744 $7,000
Q1 2024 May 15, 2024	BUY	$1.41 - $2.74 $84,649 - $164,495	60,035 Added 337.67%	77,814 $169,000
Q4 2023 Feb 14, 2024	SELL	$1.07 - $1.55 $14,426 - $20,898	-13,483 Reduced 43.13%	17,779 $27,000
Q2 2023 Aug 14, 2023	SELL	$1.41 - $1.92 $12,364 - $16,836	-8,769 Reduced 21.91%	31,262 $53,000
Q1 2023 May 12, 2023	SELL	$1.48 - $2.88 $2,927 - $5,696	-1,978 Reduced 4.71%	40,031 $60,000
Q4 2022 Feb 10, 2023	BUY	$1.19 - $1.91 $34,415 - $55,239	28,921 Added 220.97%	42,009 $67,000
Q3 2022 Nov 14, 2022	SELL	$1.23 - $1.97 $6,352 - $10,175	-5,165 Reduced 28.3%	13,088 $19,000
Q2 2022 Aug 12, 2022	BUY	$1.53 - $2.89 $5,428 - $10,253	3,548 Added 24.13%	18,253 $33,000
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $97,193 - $170,361	-36,402 Reduced 71.23%	14,705 $39,000
Q4 2021 Feb 08, 2022	BUY	$3.87 - $7.39 $75,294 - $143,779	19,456 Added 61.47%	51,107 $221,000
Q3 2021 Nov 15, 2021	BUY	$4.32 - $6.43 $28,909 - $43,029	6,692 Added 26.81%	31,651 $161,000
Q2 2021 Sep 13, 2021	BUY	$6.33 - $9.91 $157,990 - $247,343	24,959 New	24,959 $158,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

58.1M

Call Options Held

8.9K

Put Options Held

47.9K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $123M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Cytom X Therapeutics, Inc. Transaction History